DE60031315D1 - Verfahren zur Herstellung von Derivaten von i(1,5-Diaryl)pyrazol-3-ylöpropansäure - Google Patents

Verfahren zur Herstellung von Derivaten von i(1,5-Diaryl)pyrazol-3-ylöpropansäure

Info

Publication number
DE60031315D1
DE60031315D1 DE60031315T DE60031315T DE60031315D1 DE 60031315 D1 DE60031315 D1 DE 60031315D1 DE 60031315 T DE60031315 T DE 60031315T DE 60031315 T DE60031315 T DE 60031315T DE 60031315 D1 DE60031315 D1 DE 60031315D1
Authority
DE
Germany
Prior art keywords
diaryl
pyrazol
derivatives
preparation
ylpropanoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60031315T
Other languages
English (en)
Other versions
DE60031315T2 (de
Inventor
Ahmed F Abdel-Magid
Bruce D Harris
Cynthia A Maryanoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of DE60031315D1 publication Critical patent/DE60031315D1/de
Application granted granted Critical
Publication of DE60031315T2 publication Critical patent/DE60031315T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/083—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid anhydrides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE60031315T 1999-08-03 2000-08-01 Verfahren zur Herstellung von Derivaten von i(1,5-Diaryl)pyrazol-3-ylöpropansäure Expired - Lifetime DE60031315T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14699799P 1999-08-03 1999-08-03
US146997P 1999-08-03

Publications (2)

Publication Number Publication Date
DE60031315D1 true DE60031315D1 (de) 2006-11-23
DE60031315T2 DE60031315T2 (de) 2007-04-26

Family

ID=22519936

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60031315T Expired - Lifetime DE60031315T2 (de) 1999-08-03 2000-08-01 Verfahren zur Herstellung von Derivaten von i(1,5-Diaryl)pyrazol-3-ylöpropansäure
DE60015496T Expired - Lifetime DE60015496T2 (de) 1999-08-03 2000-08-01 Verfahren zur herstellung von 3-substituierte 1,5-diarylpyrozole

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60015496T Expired - Lifetime DE60015496T2 (de) 1999-08-03 2000-08-01 Verfahren zur herstellung von 3-substituierte 1,5-diarylpyrozole

Country Status (26)

Country Link
US (4) US6384233B1 (de)
EP (2) EP1413575B1 (de)
JP (2) JP4886951B2 (de)
KR (1) KR100646883B1 (de)
CN (1) CN1219771C (de)
AR (1) AR032589A1 (de)
AT (2) ATE342254T1 (de)
AU (2) AU779353B2 (de)
BR (1) BR0006978B1 (de)
CA (2) CA2636755C (de)
CZ (2) CZ299710B6 (de)
DE (2) DE60031315T2 (de)
DK (1) DK1413575T3 (de)
ES (2) ES2274171T3 (de)
HK (1) HK1040081B (de)
HU (1) HU228678B1 (de)
IL (2) IL142341A0 (de)
MY (1) MY122496A (de)
NO (1) NO318467B1 (de)
NZ (1) NZ510890A (de)
PL (1) PL201799B1 (de)
PT (2) PT1413575E (de)
RU (1) RU2243967C2 (de)
TW (1) TWI234562B (de)
WO (1) WO2001009102A2 (de)
ZA (1) ZA200103533B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1413575B1 (de) * 1999-08-03 2006-10-11 Ortho-McNeil Pharmaceutical, Inc. Verfahren zur Herstellung von Derivaten von ¬(1,5-Diaryl)pyrazol-3-yl|propansäure
US20060194807A1 (en) * 2003-04-03 2006-08-31 Cosford Nicholas D P Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5
EP1670865A2 (de) * 2003-08-19 2006-06-21 Day-Glo Color Corp. Polymere farbmittel und verfahren zum einfärben thermoplastischer harze
EP2805957A1 (de) 2013-05-23 2014-11-26 hameln rds gmbh Kristalline Formen von Trinatrium-Zink-Diethylen-triaminpentaessigsäure
CN111018785B (zh) * 2019-12-26 2022-02-11 武汉科技大学 一种1-（4-氯苯基）-3-吡唑醇的合成方法及应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164381A (en) 1986-05-29 1992-11-17 Ortho Pharmaceutical Corporation Pharmacologically active 1,5-diaryl-3-substituted pyrazoles and method for synthesizing the same
US4826868A (en) * 1986-05-29 1989-05-02 Ortho Pharmaceutical Corporation 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use
US5078780A (en) 1986-10-22 1992-01-07 Ciba-Geigy Corporation 1,5-diphenylpyrazole-3-carboxylic acid derivatives for the protection of cultivated plants
US4808613A (en) * 1986-11-21 1989-02-28 Bristol-Myers Company Rebeccamycin derivative containing pharmaceutical composition
US4898952A (en) * 1987-05-29 1990-02-06 Ortho Pharmaceutical Corporation Regioselective synthesis of a 1,5-disubstituted pyrazole
JPH0699382B2 (ja) * 1987-06-17 1994-12-07 富士写真フイルム株式会社 Ｎ−メチル−α−ジアルキルアミノアセトヒドロキサム酸誘導体
US5130421A (en) * 1988-03-24 1992-07-14 Bristol-Myers Company Production of 2',3'-dideoxy-2',3'-didehydronucleosides
US4896952A (en) * 1988-04-22 1990-01-30 International Business Machines Corporation Thin film beamsplitter optical element for use in an image-forming lens system
US5154381A (en) * 1988-12-02 1992-10-13 Malinao Michael M Microphone boom holder
US5032588A (en) * 1989-12-08 1991-07-16 Abbott Laboratories Thiazole lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids
US5117054A (en) 1991-09-26 1992-05-26 Ortho Pharmaceutical Corporation N-hydroxy, N-methyl propanamides
FR2692575B1 (fr) 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5387602A (en) 1993-08-30 1995-02-07 Ortho Pharmaceutical Corporation 1.5-diphenyl-3-(N-hydroxycarbamoyloxyalkyl)pyrazoles
US5412151A (en) * 1993-10-22 1995-05-02 Eastman Chemical Company Thermosetting coating compositions
JPH0944014A (ja) * 1995-08-03 1997-02-14 Canon Inc 加熱用フィルム、加熱加圧部材、加熱装置及び画像形成装置
US5843958A (en) * 1996-11-27 1998-12-01 Ortho Pharmaceutical Corporation Arylpyrazoles as leukotriene inhibitors
EP1413575B1 (de) * 1999-08-03 2006-10-11 Ortho-McNeil Pharmaceutical, Inc. Verfahren zur Herstellung von Derivaten von ¬(1,5-Diaryl)pyrazol-3-yl|propansäure

Also Published As

Publication number Publication date
IL142341A0 (en) 2002-03-10
JP2012051929A (ja) 2012-03-15
CA2346142A1 (en) 2001-02-08
US6613914B2 (en) 2003-09-02
AU2005201660A1 (en) 2005-05-12
KR100646883B1 (ko) 2006-11-17
HUP0103778A3 (en) 2002-07-29
US20040230060A1 (en) 2004-11-18
US6953860B2 (en) 2005-10-11
PT1144382E (pt) 2005-02-28
ES2274171T3 (es) 2007-05-16
IL171712A (en) 2010-04-29
CZ299711B6 (cs) 2008-10-29
KR20010075571A (ko) 2001-08-09
EP1413575A3 (de) 2004-10-06
CZ299710B6 (cs) 2008-10-29
US6384233B1 (en) 2002-05-07
US20020128487A1 (en) 2002-09-12
EP1413575B1 (de) 2006-10-11
AU779353B2 (en) 2005-01-20
BR0006978A (pt) 2001-06-19
ES2232482T3 (es) 2005-06-01
WO2001009102A3 (en) 2001-08-16
US20060004208A1 (en) 2006-01-05
PL347025A1 (en) 2002-03-11
EP1144382B1 (de) 2004-11-03
CA2636755A1 (en) 2001-02-08
EP1413575A9 (de) 2005-06-29
DE60031315T2 (de) 2007-04-26
AU6752600A (en) 2001-02-19
NO20011652D0 (no) 2001-04-02
ATE342254T1 (de) 2006-11-15
ZA200103533B (en) 2002-05-02
ATE281437T1 (de) 2004-11-15
CN1337951A (zh) 2002-02-27
US7247745B2 (en) 2007-07-24
NO20011652L (no) 2001-05-23
EP1144382A2 (de) 2001-10-17
US20020032336A1 (en) 2002-03-14
EP1413575A2 (de) 2004-04-28
HU228678B1 (en) 2013-05-28
PL201799B1 (pl) 2009-05-29
TWI234562B (en) 2005-06-21
JP2003506359A (ja) 2003-02-18
RU2243967C2 (ru) 2005-01-10
CZ20011202A3 (cs) 2001-09-12
NO318467B1 (no) 2005-03-21
CN1219771C (zh) 2005-09-21
DK1413575T3 (da) 2006-12-27
PT1413575E (pt) 2006-12-29
CA2346142C (en) 2008-10-14
NZ510890A (en) 2003-09-26
AR032589A1 (es) 2003-11-19
HUP0103778A2 (hu) 2002-05-29
DE60015496D1 (de) 2004-12-09
CA2636755C (en) 2010-10-19
MY122496A (en) 2006-04-29
HK1040081B (zh) 2005-05-13
JP4886951B2 (ja) 2012-02-29
HK1040081A1 (en) 2002-05-24
WO2001009102A2 (en) 2001-02-08
EP1144382A3 (de) 2002-09-11
DE60015496T2 (de) 2005-10-27
BR0006978B1 (pt) 2010-11-30

Similar Documents

Publication Publication Date Title
DE60119283D1 (de) Verfahren zur herstellung von 3-hydroxypicolinsäure-derivaten
DE69835366D1 (de) Verfahren zur herstellung von perfluorvinylethersulfonsäure-derivaten
DE60035029D1 (de) Verfahren zur herstellung von furfural
DE60019747D1 (de) Verfahren zur herstellung von fluorolefinen
DE60043261D1 (de) Verfahren zur herstellung von phenylessigsäure derivaten
DE69901519T2 (de) Verfahren zur Herstellung von 2,2'-bis (Hydroxymethyl)alkansäure
DE60024372D1 (de) Verfahren zur Herstellung von Tetraorganooxysilanen
DE60222806D1 (de) Verfahren zur herstellung von (1,4,5)-oxadiazepinderivaten
DE60029847D1 (de) Verfahren zur Herstellung von erythro 3-Amino-2-hydroxybuttersäurederivaten
DE60031231D1 (de) Verfahren zur Herstellung von 2-Alkyl-4-Isothiazolin-3-onen
DE60031315D1 (de) Verfahren zur Herstellung von Derivaten von i(1,5-Diaryl)pyrazol-3-ylöpropansäure
DE69913635D1 (de) Verfahren zur Herstellung von 1,3-Dialkyl-2-Imidazolinonderivaten
DE60004931D1 (de) Kontinuierliches Verfahren zur Herstellung von 3,5,5-Trimethylcyclohexa-3-en-1-on(beta-Isophoron)
DE60004119D1 (de) Verfahren zur Herstellung von Pentaacetyl-beta-D-Glucopyranose
DE60002254T2 (de) Verfahren zur Herstellung von 4,6-diaminoresorcin
DE60019763D1 (de) Verfahren zur herstellung von thiazolderivaten
DE60032308D1 (de) Verfahren zur Herstellung von Trichloressigsäure
DE69903610D1 (de) Verfahren zur Herstellung von 5,5'-bi-1H-Tetrazol-Salz
DE50000074D1 (de) Verfahren zur Herstellung von halogenierten 1,2-Disilaethanen
DE60104789D1 (de) Verfahren zur Herstellung von 2,4,5-Trialkylbenzaldehyden
DE50003603D1 (de) Verfahren zur Herstellung von Bistrifluormethylbenzylaminen
DE69828777D1 (de) Verfahren zur herstellung von buttersäureester-derivaten
DE59900401D1 (de) Verfahren zur Herstellung von 1,3-Dimethyl-imidazolium-4-carboxylat
DE60002513D1 (de) Verfahren zur Herstellung von Dimethyltetralin
DE50006464D1 (de) Verfahren zur Herstellung von Arylaminohydroxyanthrachinonen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition